Quick answer
Insiders filed 2 Form 4 reports showing 12 open-market purchases of Inhibrx Biosciences, Inc. (INBX) worth $1.70M on 2026-10-14.
Purchases (Form 4, code P)
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| 2026-10-14 | Lappe Mark | 2,470 | $84.07 | $207,655 |
| 2026-10-14 | Lappe Mark | 2,470 | $85.00 | $209,948 |
| 2026-10-14 | Lappe Mark | 100 | $85.76 | $8,576 |
| 2026-10-14 | Lappe Mark | 2,449 | $84.07 | $205,889 |
| 2026-10-14 | Lappe Mark | 2,451 | $85.00 | $208,333 |
| 2026-10-14 | Lappe Mark | 100 | $85.76 | $8,576 |
| 2026-10-14 | Lappe Mark | 2,470 | $84.07 | $207,655 |
| 2026-10-14 | Lappe Mark | 2,470 | $85.00 | $209,948 |
| 2026-10-14 | Lappe Mark | 100 | $85.76 | $8,576 |
| 2026-10-14 | Lappe Mark | 2,449 | $84.07 | $205,889 |
| 2026-10-14 | Lappe Mark | 2,451 | $85.00 | $208,333 |
| 2026-10-14 | Lappe Mark | 100 | $85.76 | $8,576 |
SEC sources
Updated 2026-10-14. Source: SEC EDGAR filings (linked above). Data only. Not investment advice, no buy/sell recommendation.